Saturday, December 06, 2025 | 01:24 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Unichem Labs hits record high; stock soars 30% in one week

The stock hit a record high of Rs 339, up 12%, extending its past four days rally on the BSE.

MNCs raise concerns around the definition of inventions, provisions for compulsory licensing
premium

Some major Western concerns about India’s patent framework are the definitions of inventions and provisions for compulsory licensing

SI Reporter Mumbai
Unichem Laboratories hit a record high of Rs 339, up 12%, extending its past four days rally on the BSE, after the media report suggested that Torrent Pharma is in talks to buy the company’s domestic business. The stock surpassed its previous high of Rs 334 touched on October 6, 2015 in intra-day trade.

In past one week, the stock of pharmaceuticals Company surged 30% from Rs 260, as compared to 1.6% rise in the S&P BSE Sensex.

On clarification of news report, Unichem Laboratories on Tuesday said that as and when an obligation arises, rest assured an